SAPCD2P3

Across TCGA pan-cancer cohorts, SAPCD2P3 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated SAPCD2P3 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher SAPCD2P3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SAPCD2P3 expression acts as an unfavorable survival marker, although some lineages such as UCS and BLCA show a favorable association.

COAD, UVM, and UCS are the cancer types where SAPCD2P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	All	0.830	0.921	<.001	140	view →
UVM	OS	Tertile	All	0.313	0.687	<.001	135	view →
UCS	DFS	Median	III,IV	0.586	0.251	.002	56	view →
BLCA	OS	Tertile	All	0.698	0.544	.008	35	view →
CESC	DFS	Quartile	All	0.617	0.781	.009	30	view →
KIRP	DFS	Tertile	IV	0.154	0.518	.003	30	view →
CHOL	OS	Median	III,IV	0.286	1.000	.008	30	view →
KIRC	DFS	Quartile	All	0.496	0.683	.001	23	view →
LIHC	DFS	Tertile	III,IV	0.642	0.224	.003	20	view →
GBM	OS	Median	All	0.323	0.213	.007	11	view →
PRAD	OS	Quartile	All	0.967	0.996	.020	10	view →
LUAD	DFS	Median	All	0.744	0.833	.002	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

SAPCD2P3–COAD (OS)

Open the COAD breakdown →